Updated July 30, 2026
If you live in Pennsylvania and are looking into compounded GLP-1 medications, the practical questions are usually the same three: is this legal here, how does care actually work, and what does it cost. This page answers all three. It covers how telehealth prescribing works in the Commonwealth, including the telemedicine law Pennsylvania finally put on the books in 2024, what the state expects of the pharmacies that ship compounded medication to Pennsylvania addresses, and what real providers, both national telehealth services and Pennsylvania-based clinics, currently charge. Prices in the comparison table come only from each provider’s own public pages, checked on the date above.
One disclosure before anything else: this site is operated by Gentle Health, a telehealth provider of compounded semaglutide and tirzepatide. Gentle Health appears in the comparison below on the same terms as every other provider.
How compounded GLP-1 access works in Pennsylvania
Pennsylvania permits physicians to evaluate and treat patients by telehealth, and semaglutide and tirzepatide are not controlled substances, so there is no special in-person hurdle for this category of medication. Within that framework, the process at Gentle Health looks like this:
- You complete a health intake online. It covers your medical history, current medications, prior experience with GLP-1 therapy, and your goals for weight management.
- James Simmons, MD reviews your case. Dr. Simmons is licensed to practice in Pennsylvania (license MD496905, state board record). He evaluates whether treatment is appropriate for you, and not everyone qualifies.
- If treatment is appropriate, a prescription goes to a licensed compounding pharmacy. The pharmacy prepares the medication and ships it to your Pennsylvania address, whether that is Philadelphia, Pittsburgh, Erie, or a township nobody outside your county can pronounce.
- Follow-up continues by telehealth. Dose changes, side effect questions, and check-ins happen with Dr. Simmons, not a rotating cast of unnamed staff.
The plan is cash-pay, with pricing listed publicly further down this page. There is no insurance billing and no membership fee stacked on top of the medication cost.
Worth knowing on the licensing side: Pennsylvania became a full participant in the Interstate Medical Licensure Compact on July 7, 2025, an expedited pathway that lets qualified out-of-state physicians obtain Pennsylvania licenses. However a physician gets there, the requirement is the same: anyone treating a Pennsylvania patient by telehealth needs a Pennsylvania license issued and regulated by the state’s medical board.
Pennsylvania rules worth knowing
Pennsylvania regulates this category from two directions: rules for the prescriber and rules for the pharmacy. Federal rules sit on top of both.
Telemedicine finally has a statute. For years, Pennsylvania was one of the few states with no telemedicine law at all; telehealth was practiced under general medical board standards. That changed on July 3, 2024, when Governor Shapiro signed Senate Bill 739, now Act 42 of 2024. The law’s headline provisions are about insurance: if a commercial insurer covers a service in person, it must cover the same service delivered by telemedicine when the standard of care is met, and it sets telehealth accessibility standards for Medicaid and CHIP. Just as important for patients, as the health law firm Lamb McErlane summarized, the Act gives telemedicine in Pennsylvania a statutory framework and legal clarity it previously lacked. The practical requirements have not changed: the physician must hold a Pennsylvania license, and the standard of care is the same as for an in-person visit.
The pharmacy side. Most compounded GLP-1 prescriptions for Pennsylvania patients are filled by out-of-state compounding pharmacies, and Pennsylvania regulates these directly. Under Section 390-4.1 of the Pennsylvania Pharmacy Act, a nonresident pharmacy must register with the State Board of Pharmacy, renew that registration biennially, and may not ship, mail, or deliver prescription medication into the state until the Board has issued its certificate of registration. The Board’s operating rules live in 49 Pa. Code Chapter 27. In short, the pharmacy filling your prescription has to answer to Pennsylvania’s Board, not just its home state’s. As of this writing (checked July 30, 2026), the Pennsylvania State Board of Pharmacy has not published guidance specific to compounded GLP-1s; the general compounding and nonresident-registration rules above are what govern.
The federal backdrop. The FDA resolved the tirzepatide shortage in December 2024 and the semaglutide shortage in February 2025, and has since clarified its policies for compounders as supply stabilized. Large-scale compounding of copies of commercially available products has wound down, and in 2026 the agency has moved to restrict bulk compounding of these ingredients by outsourcing facilities further, as reported by Pharmacy Times. What remains is traditional patient-specific compounding under Section 503A: a licensed prescriber writes a prescription for an individual patient based on that patient’s clinical needs, and a state-licensed pharmacy fills it. That is the pathway legitimate providers, Gentle Health included, operate under. Compounded medications are not FDA-approved, and any provider that glosses over that is not being straight with you.
Compounded semaglutide in Pennsylvania
Semaglutide is a GLP-1 receptor agonist. It mimics a hormone your body produces after eating, which slows stomach emptying, moderates blood sugar, and reduces appetite. Compounded semaglutide is the same active ingredient prepared by a licensed compounding pharmacy for an individual patient, dispensed in a vial (for injection) or an oral form rather than a manufacturer’s fixed-dose pen. Compounded medications are not FDA-approved, and clinical trial results for brand-name products do not transfer to compounded versions.
For Pennsylvania patients, Gentle Health offers compounded semaglutide in two forms:
- Oral semaglutide: $112 per month. No needles. A daily form for people who want to start with the lower-cost option or simply prefer not to inject.
- Injectable semaglutide: $135 per month. A once-weekly subcutaneous injection, shipped with supplies.
Both prices are flat and cash-pay. There is no membership fee, no dose-based price escalation, and no insurance paperwork, because insurance is not billed at all. Whether semaglutide is appropriate for you, and at what dose, is Dr. Simmons’s call after reviewing your health history. Treatment is subject to medical evaluation, and some patients, such as those with a personal or family history of medullary thyroid carcinoma, are not candidates.
Compounded tirzepatide in Pennsylvania
Tirzepatide works on two receptors rather than one: GLP-1 and GIP, a second gut hormone involved in appetite and metabolism. Compounded tirzepatide, like compounded semaglutide, is prepared by a licensed compounding pharmacy for a specific patient under a physician’s prescription, and it is not FDA-approved.
Gentle Health offers injectable compounded tirzepatide at $169 per month, cash-pay, with the same structure as the semaglutide program: evaluation and ongoing care by James Simmons, MD, medication shipped from a licensed compounding pharmacy to your Pennsylvania address, and no membership fee layered on top. Tirzepatide is typically the more expensive of the two medications across the market, as the comparison table below shows, so the practical question for many patients is whether to start with semaglutide and reassess. That is a conversation to have during your evaluation rather than a decision to make from a pricing page.
Provider options in Pennsylvania: comparison table
Methodology: providers listed alphabetically; all prices taken from each provider’s own public pages on July 30, 2026; where a price is not published, we write “See site” rather than guessing.
| Provider | Care model | Compounded semaglutide (cash/mo) | Compounded tirzepatide (cash/mo) | Serves Pennsylvania | Insurance | Source |
|---|---|---|---|---|---|---|
| Gentle Health | Telehealth; care by James Simmons, MD | $112 (oral) / $135 (injectable) | $169 (injectable) | Yes | Cash-pay only; insurance not billed | Gentle Health pricing (verified 2026-07-30) |
| Mochi Health | Telehealth; membership plus medication billed separately | See site; membership is $79/mo ($39 first month) | See site | Yes (site Pennsylvania page) | Site states it works with Pennsylvania insurers on coverage and prior authorizations | joinmochi.com (verified 2026-07-30) |
| OrderlyMeds | Telehealth; all-inclusive plans | $149/mo standard ($74/mo two-month starter, new customers) | $299/mo standard ($149/mo two-month starter, new customers) | Yes (site states providers licensed in all 50 states) | Not required; cash-pay; HSA/FSA accepted | orderlymeds.com (verified 2026-07-30) |
| Sanctuary Wellness Institute | Telehealth from a Pennsylvania-based practice (Chester Springs and Lemoyne, PA); includes lab work | $225 first month, then $275/mo (flat program rate, either medication per evaluation) | Same flat program rate; not priced separately by drug | Yes (Pennsylvania-headquartered; city pages statewide) | See site | sanctuarywellnessinstitute.com (verified 2026-07-30) |
| Trimi Health | Telehealth; annual and monthly plans | $99/mo on annual plan (monthly plans from $175/mo) | $125/mo on annual plan (monthly plans from $235/mo) | Yes (site Pennsylvania page) | Not required; cash-pay; FSA/HSA eligible | trytrimi.com (verified 2026-07-30) |
A few honest notes on reading this table. The pricing structures are genuinely different, not just differently sized numbers. Trimi’s headline prices require paying for a year up front; its month-to-month prices are considerably higher. OrderlyMeds uses starter pricing that steps up to the standard rate after two months. Mochi separates a monthly membership fee from the medication cost, so the all-in monthly figure is higher than either line item. Sanctuary bundles lab work and visits from a Pennsylvania-based practice into one flat rate that does not distinguish between the two medications. Gentle Health’s numbers are flat monthly prices with no membership fee and no annual commitment. None of these structures is objectively right; they suit different people, which is why we list them rather than rank them.
Pennsylvania FAQ
Is compounded semaglutide legal in Pennsylvania?
Yes, through the patient-specific pathway. A Pennsylvania-licensed prescriber writes a prescription for an individual patient, and a compounding pharmacy fills it. Out-of-state pharmacies shipping into the Commonwealth must be registered with the Pennsylvania State Board of Pharmacy as nonresident pharmacies under Section 390-4.1 of the Pharmacy Act before they may ship medication to Pennsylvania residents. Compounded medications are not FDA-approved.
Can a doctor really prescribe this in Pennsylvania without seeing me in person?
Yes. Pennsylvania’s telemedicine statute, Act 42 of 2024, recognizes telemedicine delivered by licensed providers at the same standard of care as an in-person visit. The physician must hold a Pennsylvania license and perform an evaluation adequate to establish that treatment is appropriate. Semaglutide and tirzepatide are not controlled substances, so the tighter rules that apply to controlled-substance prescribing by telehealth do not apply to them.
Who actually provides my care at Gentle Health if I’m in Pennsylvania?
James Simmons, MD. He is licensed to practice medicine in Pennsylvania (license MD496905, verifiable through the state’s PALS license search). He performs the initial evaluation, writes the prescription if treatment is appropriate, and handles follow-up care and dose adjustments.
Didn’t Pennsylvania pass a law making insurers cover telemedicine? Does that mean my insurance covers this?
Two different things. Act 42 of 2024 requires insurers that cover a service in person to cover the same service delivered by telemedicine. That is about the visit format, not about which medications your plan covers. Insurance plans, including Pennsylvania Medicaid, rarely cover compounded medications, which is why this market is almost entirely cash-pay. Gentle Health does not bill insurance; the listed prices ($112, $135, $169 per month) are the full cost. If your plan covers brand-name GLP-1 therapy, that is worth exploring with your own physician and insurer, and it is a different product and pathway from anything on this page.
How does the medication get to me in Pennsylvania?
After Dr. Simmons approves treatment, the prescription goes to a licensed compounding pharmacy registered to ship into Pennsylvania, which sends the medication and supplies to your address. Cold-chain packaging is standard for injectable peptides. Shipping timelines vary by pharmacy, typically within about a week of prescription approval.
I split time between Pennsylvania and New Jersey, Delaware, or New York. Does that matter?
It can. Telehealth rules generally attach to where the patient is physically located at the time of the visit, and each state licenses separately. If you are usually in Pennsylvania, do your visits from Pennsylvania. If your situation is more complicated, raise it during your evaluation so care is set up correctly.
Why do Pennsylvania prices range from around $99 to $275 a month for what sounds like the same medication?
Because you are not just buying medication; you are buying a pricing structure and a care structure. The lowest headline numbers usually require an annual prepay or expire after a starter period. Mid-range flat rates like Gentle Health’s include telehealth care and shipping with no membership fee. The higher flat rates, like Sanctuary’s, bundle lab work and a Pennsylvania-based practice’s visit structure into the price. Compare what is actually included and what you are committing to, not just the headline number.
Reviewed by James Simmons, MD
Last updated: August 7, 2026
Compounded medications are not FDA-approved. Treatment subject to medical evaluation.